|Tested species reactivity||Human|
|Published species reactivity||Human, Mouse, Not Applicable, Rhesus monkey|
|Host / Isotype||Mouse / IgG2b|
|Immunogen||Activated human peripheral blood mononuclear cells|
|Storage buffer||PBS, pH 7.4, with 0.2% BSA|
|Contains||0.09% sodium azide|
|Storage Conditions||4° C|
|Tested Applications||Dilution *|
|Flow Cytometry (Flow)||Assay Dependent|
|Immunohistochemistry (Frozen) (IHC (F))||2-4 µg/ml|
|Western Blot (WB)||1:100-1:10,000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
MA5-11966 targets Human MHC II (HLA-DR) in FACS, WB and IHC (F) applications and shows reactivity with Human samples. This antibody does not react with mouse tissue in Western blot applications.
The MA5-11966 immunogen is activated human peripheral blood mononuclear cells.
HLA-DR, like other MHC class II molecules, is a transmembrane glycoprotein composed of an alpha chain (36 kDa) and a beta chain (27 kDa). It is expressed primarily on antigen presenting cells such as B lymphocytes, monocytes, macrophages, thymic epithelial cells and activated T lymphocytes. Three loci, DR, DQ and DP, encode the major expressed products of the human class II region. The human MHC class II molecules bind intracellularly processed peptides and present them to T-helper cells. They therefore have a critical role in the initiation of the immune response.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection.
MA5-11966 was used in flow cytometry to study the cytolytic effector capacity of HIV-specific CD8+ T cells
|Demers KR,Makedonas G,Buggert M,Eller MA,Ratcliffe SJ,Goonetilleke N,Li CK,Eller LA,Rono K,Maganga L,Nitayaphan S,Kibuuka H,Routy JP,Slifka MK,Haynes BF,McMichael AJ,Bernard NF,Robb ML,Betts MR||PLoS pathogens (12:null)||2016|
Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds.
MA5-11966 was used in immunohistochemistry - paraffin section to optimize rhesus monkey decellularized kidney scaffolds
|Nakayama KH,Lee CC,Batchelder CA,Tarantal AF||PloS one (8:null)||2013|
Amyloid-ß oligomers stimulate microglia through a tyrosine kinase dependent mechanism.
MA5-11966 was used in immunohistochemistry to study the role of tyrosine kinase activity in the stimulation of microglia by oligomers of beta-amyloid
|Dhawan G,Floden AM,Combs CK||Neurobiology of aging (33:2247)||2012|
Alzheimer's disease modifies progenitor cell expression of monoamine oxidase B in the subventricular zone.
MA5-11966 was used in immunohistochemistry to study the effect of Alzheimer's disease on the expression of progenitor cell monoamine oxidase B
|Pugliese M,Rodríguez MJ,Gimeno-Bayon J,Pujadas L,Billett EE,Wells C,Mahy N||Journal of neuroscience research (88:2588)||2010|
Combined therapy of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma: clinical safety.
MA5-11966 was used in immunohistochemistry to study the use of transcatheter hepatic arterial embolization with intratumoral dendritic cell infusion for hepatocellular carcinoma
|Nakamoto Y,Mizukoshi E,Tsuji H,Sakai Y,Kitahara M,Arai K,Yamashita T,Yokoyama K,Mukaida N,Matsushima K,Matsui O,Kaneko S||Clinical and experimental immunology (147:296)||2007|
Immunohistochemical analysis of orbital connective tissue specimens of patients with active Graves ophthalmopathy.
MA5-11966 was used in immunohistochemistry to study the cells infiltrating orbital connective tissue in patients with active Graves opthalmopathy
|Avunduk AM,Avunduk MC,Pazarli H,Oguz V,Varnell ED,Kaufman HE,Aksoy F||Current eye research (30:631)||2005|
Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan: clinical and immunological findings.
MA5-11966 was used in immunohistochemistry to evaluate specific tumor vaccines against stage IV renal cell cancer
|Tani K,Azuma M,Nakazaki Y,Oyaizu N,Hase H,Ohata J,Takahashi K,OiwaMonna M,Hanazawa K,Wakumoto Y,Kawai K,Noguchi M,Soda Y,Kunisaki R,Watari K,Takahashi S,Machida U,Satoh N,Tojo A,Maekawa T,Eriguchi M,Tomikawa S,Tahara H,Inoue Y,Yoshikawa H,Yamada Y,Iwamoto A,Hamada H,Yamashita N,Okumura K,Kakizoe T,Akaza H,Fujime M,Clift S,Ando D,Mulligan R,Asano S||Molecular therapy : the journal of the American Society of Gene Therapy (10:799)||2004|
Dynamics of immune granuloma formation in a Leishmania braziliensis-induced self-limiting cutaneous infection in the primate Macaca mulatta.
MA5-11966 was used in flow cytometry and immunohistochemistry (paraffin) to study the host inflammatory granulomatous response that controls cutaneous leishmaniasis using a macaque model.
|Souza-Lemos C,de-Campos SN,Teva A,Côrte-Real S,Fonseca EC,Porrozzi R,Grimaldi G||The Journal of pathology (216:375)||2008|
Human macrophage lectin specific for galactose/N-acetylgalactosamine is a marker for cells at an intermediate stage in their differentiation from monocytes into macrophages.
MA5-11966 was used in flow cytometry and immunohistochemistry (frozen) to determine the expression of a human macrophage lectin specific for galactose/N-acetylgalactosamine during macrophage differentiation.
|Higashi N,Morikawa A,Fujioka K,Fujita Y,Sano Y,Miyata-Takeuchi M,Suzuki N,Irimura T||International immunology (14:545)||2002|
Identification of new MHC-restriction elements for presentation of the p210(BCR-ABL) fusion region to human cytotoxic T lymphocytes.
MA5-11966 was used in blocking or activating experiment to investigate the immune response against the p210(BCR-ABL) fusion region in chronic myelogenous leukemia
|Sun JY,Senitzer D,Forman SJ,Chatterjee S,Wong KK||Cancer immunology, immunotherapy : CII (52:761)||2003|